Human activity detection and action recognition in videos using convolutional neural networks

Human activity recognition from video scenes has become a significant area of research in the field of computer vision applications. Action recognition is one of the most challenging problems in the area of video analysis and it finds applications in human-computer interaction, anomalous activity detection, crowd monitoring and patient monitoring. Several approaches have been presented for human activity recognition using machine learning techniques. The main aim of this work is to detect and track human activity, and classify actions for two publicly available video databases. In this work, a novel approach of feature extraction from video sequence by combining Scale Invariant Feature Transform and optical flow computation are used where shape, gradient and orientation features are also incorporated for robust feature formulation. Tracking of human activity in the video is implemented using the Gaussian Mixture Model. Convolutional Neural Network based classification approach is used for database training and testing purposes. The activity recognition performance is evaluated for two public datasets namely Weizmann dataset and Kungliga Tekniska Hogskolan dataset with action recognition accuracy of 98.43% and 94.96%, respectively. Experimental and comparative studies have shown that the proposed approach outperformed state-of the art techniques

Isolation and screening lactic acid bacteria for riboflavin production and their use for bioenrichment of curd

As many as 47 lactic acid bacteria were isolated from various vegetables and fruits and raita collected from local households and characterized. All of them were Gram positive and catalase negative. The isolates were screened for riboflavin production. The riboflavin production varied from 0.86 to 10.90 mg L-1. The isolate Ra1 produced the highest riboflavin (10.90 ppm). Incidentally, it also produced 5.6 per cent lactic acid and 21.4 ppm exopolysaccharide (EPS). Similarly, N2 and F2 isolates produced 10.90 and 10.20 ppm riboflavin and 21.17 and 21.24 ppm EPS, respectively. These three selected isolates were used for preparing a functional curd andevaluated. The curd produced by inoculating N2 and Ra1 were of very good quality with excellent flavor, taste and texture and smooth cutting quality. Ra1 produced a functional curd with the highest riboflavin content (13.97 ppm). N2 and RA1 resulted in very high acceptability index of 95.37 and 94.44 per cent, respectively. The betterorganoleptic parameters of the functional curd may also be due to high lactic acid and exopolysaccharide production by these isolates. Thus, by inoculating riboflavin synthesizing LAB isolates to curd, riboflavin-enriched functional curd with enhanced consumer appeal, can be produced

Real world evidence of effectiveness and safety of an oral formulation containing un-denatured type-II collagen 40 mg and aflapin 100 mg (HAPID®) in the management of osteoarthritis of knee: findings of a prospective, multi-center, observational study

Background: Osteoarthritis (OA) of knee is a common progressive multifactorial joint disorder affecting the quality of life, and surgical repair is the final option which has substantial impact on healthcare costs. This real-world study evaluates the efficacy and safety of an oral formulation containing UC-II and aflapin (Boswellia serrata extract enriched in 3-O-acetyl-11-keto-beta-boswellic acid) for treatment of OA of knee.Methods: Data of 505 ambulatory adult patients (study duration-Jul-21 to Jul-22) of either gender (227 M, 278 F) having OA of knee, and who received study treatment (capsule HAPID®, Wockhardt, India) once daily for a period of up to 90 days were included for the study after obtaining informed written consent. Primary outcomes were mean change in Western Ontario and McMaster universities OA index (WOMAC) scores from baseline through day 90 (total and sub-scales for joint pain, joint stiffness, and physical function), and change in 0-10 visual analogue scale (VAS) score for pain.Results: About 285 (56.4%) patients were newly diagnosed, majority (63.4%) were having grade 2 severity of OA (Kellgren and Lawrence grade). The mean (SD) baseline total WOMAC scores improved from 60.94 (23.60) at baseline to 26.42 (22.19) on day 90. Significant improvements were seen starting from day 5 (p=0.023) and progressively up to day 90 (p<0.0001).Conclusions: The excellent safety and efficacy profile of combination therapy with aflapin and UC-II makes it a desirable pharmacological treatment modality for management of patients of knee OA

All India Co-ordinated Research Project on Biological Control of Crop Pests

Not AvailableSurveys were undertaken to document the fauna of insects, spiders and entomopathogenic nematodesacross India despite the travel restrictions due to COVID-19. The expeditions undertaken yielded several species of natural enemies viz.,Chalcididae (66.32%), Eulophidae (19.94%), Pteromalidae (4.14%) and Encyrtidae (3.37%) of Hymenoptera and 14 species of trichogrammatids representing 7 genera. The predominant genera of hymenopteran insect parasitoids were identified as Dirhinus Dalman (30.47%) followed by Brachymeria Westwood (27.73%), Hockeria Walker (22.27%) and Antrocephalus Kirby (18.75%). Revisionary studies of the braconid parasitoid, Apanteles sp. ater-group including subgroup eublemmae of the genus (Hymenoptera: Braconidae) of the Oriental region was carried out with an illustrated key, in which a total of 97 species were recorded and illustrated. Three species of tachinid flies, Peribaea orbata on larva of Spodoptera litura, Halidaia luteicornis on larva of Parnara sp., Sturmiopsis inferens on larva of Sesamia inferens and Carcelia sp. from the larvae of Helicoverpa armigera (Noctuidae) were identified and described. The spider fauna of rice ecosystem was documented, where six species of long jawed orb weaver, Tetragnatha species have been described of which T. keyserlingi was the predominant species across the surveyed locations in Tamil Nadu. The species, Tetragnathanitens collected from Tamil Nadu and Telangana was the first report from India. The spitting spider, Scytodes fusca Walckenaer of family Scyotidae was redescribed with documentation of variations in the vulval pattern of the female and theory about the introduction of this Pantropical species to India.Not Availabl

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

Objectives: ANCA-associated vasculitis (AAV) can affect all age groups. We aimed to show that differences in disease presentation and 6 month outcome between younger- A nd older-onset patients are still incompletely understood. Methods: We included patients enrolled in the Diagnostic and Classification Criteria for Primary Systemic Vasculitis (DCVAS) study between October 2010 and January 2017 with a diagnosis of AAV. We divided the population according to age at diagnosis: <65 years or ≥65 years. We adjusted associations for the type of AAV and the type of ANCA (anti-MPO, anti-PR3 or negative). Results: A total of 1338 patients with AAV were included: 66% had disease onset at <65 years of age [female 50%; mean age 48.4 years (s.d. 12.6)] and 34% had disease onset at ≥65 years [female 54%; mean age 73.6 years (s.d. 6)]. ANCA (MPO) positivity was more frequent in the older group (48% vs 27%; P = 0.001). Younger patients had higher rates of musculoskeletal, cutaneous and ENT manifestations compared with older patients. Systemic, neurologic,cardiovascular involvement and worsening renal function were more frequent in the older-onset group. Damage accrual, measured with the Vasculitis Damage Index (VDI), was significantly higher in older patients, 12% of whom had a 6 month VDI ≥5, compared with 7% of younger patients (P = 0.01). Older age was an independent risk factor for early death within 6 months from diagnosis [hazard ratio 2.06 (95% CI 1.07, 3.97); P = 0.03]. Conclusion: Within 6 months of diagnosis of AAV, patients >65 years of age display a different pattern of organ involvement and an increased risk of significant damage and mortality compared with younger patients

Epigenetic modulators as therapeutic targets in prostate cancer

Prostate cancer is one of the most common non-cutaneous malignancies among men worldwide. Epigenetic aberrations, including changes in DNA methylation patterns and/or histone modifications, are key drivers of prostate carcinogenesis. These epigenetic defects might be due to deregulated function and/or expression of the epigenetic machinery, affecting the expression of several important genes. Remarkably, epigenetic modifications are reversible and numerous compounds that target the epigenetic enzymes and regulatory proteins were reported to be effective in cancer growth control. In fact, some of these drugs are already being tested in clinical trials. This review discusses the most important epigenetic alterations in prostate cancer, highlighting the role of epigenetic modulating compounds in pre-clinical and clinical trials as potential therapeutic agents for prostate cancer management.info:eu-repo/semantics/publishedVersio

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Field evaluation of the entomopathogenic nematodes against the white grub, Leucopholis lepidophora Blanchard (Coleoptera: Scarabaeidae)

Abstract The ability of entomopathogenic nematodes to suppress larval populations of the white grub, Leucopholis lepidophora Blanchard (Coleoptera: Scarabaeidae), infesting the areca nut palm (Areca catechu) was investigated under field conditions over a 2-year period (2015–2017). Heterorhabditis indica at two application rates (1.7 × 105 and 3.5 × 105 IJs palm−1) caused higher percentage reduction of L. lepidophora larvae than Steinernema abbasi and chlorpyrifos. Chlorpyrifos-treated plots caused higher percentage of reduction of the grub larvae than S. abbasi at the lowest rate (1.7 × 105 IJs palm−1). However, S. abbasi at 3.5 × 105 IJs palm−1 performed at least equally well than the chlorpyrifos treatment. The kernel yield from H. indica-treated plots at 3.5 × 105 IJ palm− 1 was 85.4% higher than those from water control and 33.3% higher than that in the chlorpyrifos treatment. The kernel yields varied significantly among different treatments. The cost-benefit analysis showed that H. indica is a promising biocontrol agent for the management L. lepidophora control in areca nut field

Not Available

Not AvailableRoot-knot nematodes cause hypertrophy and hyperplasia of the vascular and cortical root tissues that reduce the absorption and transport of nutrients and water from soil. Aboveground symptoms are mistaken as nutrient deficiencies. The farmers tend to apply higher doses of fertilizers than necessary for a nematode-free crop, that not only causes economic loss but also avoidable soil and groundwater pollution. The nitrogen (N), phosphorus (P), potassium (K), iron (Fe) and zinc (Zn) contents were determined in the rhizosphere soil and leaves of a non-basmati Pusa-44 and a basmati Pusa Sugandh-5 cultivars of rice grown in soil infested with varying levels of Meloidogyne graminicola under pot and field conditions. The N, P, K, Fe and Zn contents in the rice leaves were significantly reduced in both the rice cultivars infestated with M. graminicola under both pot and field conditions. The degree of reduction did not significantly differ in the two cultivars. Pusa Sugandh-5 had relatively greater biomass than Pusa-44, but both the cultivars appeared to be similarly susceptible to M. graminicola. The residual contents of N, P, K, Fe and Zn in soil were more with increasing nematode population. Thus, the nutrients remained unutilized in the soil while the plant suffered severe nutrient deficiencies and growth reduction in the presence of nematode infestation.Not Availabl

Not Available

Not AvailableBiological control potential of two entomopathogenic nematodes, Heterorhabditis indica and Steinernema carpocapsae, was tested against neonate-, and third-instar grubs of Orycuts rhinoceros in laboratory and micro-plot experiments. The main aim of the study was to develop an efficient sustainable control method against the pest. With this we could develop a strategy of coconut production with the intention of diminishing or even preventing the appearance of pest resistance to insecticides. In the laboratory experiments, S. carpocapsae and H. indica were highly virulent to neonate grubs. Neonate grubs were susceptible to S. carpocapsae followed by H. indica. The virulence of the nematode species relative to each other differed greatly to neonate grubs but not to the 3rd instar grubs. In all the experiments, mortality of rhinoceros grubs varied significantly among nematode dose and days after treatment. In comparison of neonate grubs mortality, 3rd instar grubs require more number of nematodes. The dosage and time mortality relationship of S. carpocapsae and H. indica against the neonate and 3rd instar stage of O. rhinoceros indicated that as the dosage increased the susceptibility also increased. The susceptibility of the developmental stages of O. rhinoceros differed greatly among tested concentrations of nematode species and time. Our observations, combined with those of previous studies on other nematode and white grub species, show that nematode virulence against rhinoceros grub developmental stages varies with time and nematode concentration.Not Availabl